Quantum BioPharma's MS drug candidate nears phase 2 trials
Go back to Quantum BioPharma's MS drug candidate nears phase 2 trials| Quantum Technology Corp (NASDAQ: QNTM) | Delayed: 3.72 +0.07 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.65 | 52 Week High | $2.00 | |||
| Open | $3.63 | 52 Week Low | $0.10 | |||
| Day High | $3.88 | P/E | N/A | |||
| Day Low | $3.63 | EPS | $0.00 | |||
| Volume | 191,755 | |||||
